Company Filing History:
Years Active: 2012
Title: Heath M Guay: Innovator in Binding Proteins and Immune Modulation
Introduction
Heath M Guay is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of immunology through his innovative work on binding proteins. His research focuses on the interleukin-21 receptor, which plays a crucial role in immune responses.
Latest Patents
Heath M Guay holds 1 patent titled "Methods of treatment utilizing binding proteins of the interleukin-21 receptor." This invention provides binding proteins and antigen-binding fragments that specifically target the human interleukin-21 receptor (IL-21R). The binding proteins can function as antagonists of IL-21R activity, thereby modulating immune responses. The disclosed methods and compositions are applicable in diagnosing, treating, and preventing IL-21R-associated disorders, including inflammatory disorders, autoimmune diseases, allergies, and transplant rejection.
Career Highlights
Heath M Guay is associated with Wyeth, a company known for its research and development in pharmaceuticals. His work has contributed to advancements in treatments that address various immune system disorders.
Collaborations
Heath has collaborated with notable colleagues, including Laird Bloom and Davinder Gill, to further his research and innovations in the field.
Conclusion
Heath M Guay's contributions to the understanding and treatment of immune system disorders through his innovative patents highlight his role as a significant inventor in the field of immunology. His work continues to impact the development of therapeutic strategies for various health conditions.